Kopran's EU GMP inspection at Khopoli facility closes.

Kopran's EU GMP inspection at Khopoli facility closes. The Medicine Authority of the European Union completed its Good Manufacturing Practice audit at Kopran’s formulation plant. Closure indicates no immediate regulatory concerns. This is a routine compliance update with no financial impact.

📊 STOCKS: $KOPRAN | 🏢 SECTOR: Pharma | #LOWIMPACT #GMP